🔗 Share this article

An underground market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are urged to message these accounts privately for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Additionally, a flourishing market exists on Telegram, where groups with thousands of members share “before and after” photos, administration instructions and claims of next-day British shipping. Vendors promote the drug there before redirecting customers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Experts Voice Worries

However, physicians and chemists have cautions that the distribution of what is still an unapproved drug in the UK is worrisome and could result in individuals administering substances of unknown origin.

Some experts said the demand for retatrutide could be connected to the rising cost of approved weight loss products such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.

Several influencers try to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach medicines, marketing, and customer regulations, potentially leading to penalties, prosecution or imprisonment.

Platform Response and Content Removal

According to the social media company, the platform has taken down violative content and banned associated keywords and query recommendations. The company stated it was committed to keeping the service safe and investing in strengthening enforcement strategies.

Online Trading Operations

Investigations also discovered communities with up to nine thousand members selling the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays groups with thousands of members, filled with photos of weight loss, positive reviews and detailed guides for mixing or administering at home.

Within moments of joining one group, a vendor posted contact information, where most purchases occur. The vendor provided an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about weight, medical conditions or previous experience.

Item Details and Costs

Inside these communities, messages display dark colored packages with Royal Mail stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service stated it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering substances they can’t verify. Even if the science behind retatrutide is sound, these online versions may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has already encountered individuals injured by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These materials could be impure or improperly measured.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company experimental product not yet authorized … may expose users to possibly serious health risks”.